Find a Tender
complete
Official procurement procedure
NHS Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - 1 June 2026
No classification published
Location not published
Published value
£483,000,001
Submission deadline 9 Jan 2026, 13:00 GMT
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - 1 June 2026". Published status: complete. Published value: £483,000,001. 4 published lots. Recorded submission deadline: 9 Jan 2026, 13:00 GMT. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Closed 9 Jan 2026, 13:00 GMT |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £483,000,001 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published1 May 2026, 11:53 BST | Last source update1 May 2026, 11:53 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-05e360 | ||
What is being bought
NHS National Proprietary Pharmaceuticals – Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins 1 June 2026 – CM/PHR/25/5727
Period of Framework Agreement: 1 June 2026 to 31 May 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CM/PHR/25/5727/01 - High Use Lines Regionally Awarded to 1 Supplier
CM/PHR/25/5727/02 - Not Regionally Awarded Lines
CM/PHR/25/5727/03 - All Lines in Lot 1 and Lot 2, available only to Aseptic Units from any Supplier
CM/PHR/25/5727/04 - Added Value Services
What changed
From the official release history
- Official notice release published
1 May 2026, 11:53 BST - tender value changed
10 Mar 2026, 15:23 GMT - Status changed to complete
10 Mar 2026, 15:23 GMT - Official notice release published
10 Mar 2026, 15:23 GMT - Submission deadline changed to published date
10 Mar 2026, 15:23 GMT - Official notice release published
15 Dec 2025, 10:35 GMT - Submission deadline changed to 9 Jan 2026, 13:00 GMT
15 Dec 2025, 10:35 GMT - Published value updated to £483,000,001
18 Nov 2025, 14:00 GMT - Status changed to active
18 Nov 2025, 14:00 GMT - Official notice release published
18 Nov 2025, 14:00 GMT - Submission deadline changed to 18 Dec 2025, 13:00 GMT
18 Nov 2025, 14:00 GMT - Buyer information updated
18 Nov 2025, 14:00 GMT
Lots and requirements (4)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
1 May 2026, 11:53 BST - Submission deadline
9 Jan 2026, 13:00 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 28 Apr 2026, 00:00 BST · £87,586,666 - Contract active
Signed 28 Apr 2026, 00:00 BST · £171,540,038 - Contract active
Signed 28 Apr 2026, 00:00 BST · £19,060,004 - Contract active
Signed 28 Apr 2026, 00:00 BST · £30,000,000
Commercial outcome and competition
Awards B. BRAUN MEDICAL LIMITED, BAXTER HEALTHCARE LIMITED Not published · Not published · active Aguettant Limited, B. BRAUN MEDICAL LIMITED, BAXTER HEALTHCARE LIMITED, ENNOGEN HEALTHCARE INTERNATIONAL LIMITED, FRESENIUS KABI LIMITED, Tecrapharm (Germany) GmbH Not published · Not published · active Aguettant Limited, B. BRAUN MEDICAL LIMITED, BAXTER HEALTHCARE LIMITED, ENNOGEN HEALTHCARE INTERNATIONAL LIMITED, FRESENIUS KABI LIMITED, Tecrapharm (Germany) GmbH Not published · Not published · active BAXTER HEALTHCARE LIMITED, Eleanor Hospital Logistics, THE TPS HEALTHCARE GROUP LIMITED Not published · Not published · active |
Contracts CM/PHR/25/5727/01 - High Use Lines Regionally Awarded to 1 Supplier £87,586,666 · signed 28 Apr 2026, 00:00 BST · active Contract period: 1 Jun 2026, 00:00 BST — 31 May 2028, 23:59 BST CM/PHR/25/5727/02 - Not Regionally Awarded Lines £171,540,038 · signed 28 Apr 2026, 00:00 BST · active Contract period: 1 Jun 2026, 00:00 BST — 31 May 2028, 23:59 BST CM/PHR/25/5727/03 - All Lines in Lot 1 and Lot 2, available only to Aseptic Units from any Supplier £19,060,004 · signed 28 Apr 2026, 00:00 BST · active Contract period: 1 Jun 2026, 00:00 BST — 31 May 2028, 23:59 BST CM/PHR/25/5727/04 - Added Value Services £30,000,000 · signed 28 Apr 2026, 00:00 BST · active Contract period: 1 Jun 2026, 00:00 BST — 31 May 2028, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published